Clinical Trial Update: WelChol® and Sulfonylurea in Treating Patients With Type 2 Diabetes [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating WelChol (colesevelam) in combination with a sulfonylurea in patients with Type 2 diabetes mellitus has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Sulfonylurea (unspecified)
• Welchol (colesevelam hydrochloride)

Snippet

Sponsor: Daiichi Sankyo | Conditions: Type 2 Diabetes | Phase 3 | Status: COMPLETED